Singh Sweta, Florez Hector
Savitribai Phule Pune University, Pune, India.
Universidad Distrital Francisco Jose de Caldas, Bogota, Colombia.
F1000Res. 2020 Oct 6;9:1203. doi: 10.12688/f1000research.26731.1. eCollection 2020.
In 2020, the world has struggled to deal with coronavirus disease 2019 (COVID-19), which started in 2019 in China and has spread throughout the globe, affecting at least 31,175,835 humans globally and claiming 962,634 lives reported till 22nd September, 2020 by the World Health Organization. The main causative agent for this disease is known as severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). So far, there is no cure or proven therapeutics available till date. Therefore, we undertook this study to find the most probable drug candidate through a bioinformatics study. Thus, we virtually screened the Zinc natural database using HTVS tool through molecular docking studies to analyze molecules recommended for the treatment of COVID-19. Ramipril benzyl ester, propafenone dimer and Lariciresinol are three important drugs found from the present study due to their medicinal application which could be helpful in treating the disease. Stylopine, quillaic acid, cinobufagin, vitisinol C, segetalin A, scopolamine, 3-oxo glycyrrhetinic acid, conchinone B, lactimidomycin and cardinalins 4 are the other lead molecules that could be used as therapeutics against COVID-19 disease. The studied molecules could act as an effective inhibitory drug against COVID-19.
2020年,全世界都在努力应对2019冠状病毒病(COVID-19),该病于2019年在中国出现并已蔓延至全球,截至2020年9月22日,全球至少有31175835人感染,962634人死亡。世界卫生组织报告称,这种疾病的主要病原体是严重急性呼吸综合征冠状病毒2(SARS-COV-2)。到目前为止,尚无治愈方法或经证实的治疗方法。因此,我们开展了这项研究,通过生物信息学研究找到最有可能的候选药物。因此,我们通过分子对接研究,使用HTVS工具对锌天然数据库进行了虚拟筛选,以分析推荐用于治疗COVID-19的分子。雷米普利苄酯、普罗帕酮二聚体和落叶松脂醇是本研究中发现的三种重要药物,因其药用价值可能有助于治疗该疾病。番荔枝碱、奎来酸、华蟾酥毒基、葡萄素C、黑麦草内酯A、东莨菪碱、3-氧代甘草次酸、贝壳杉烯二酮B、乳酰咪唑霉素和红衣主教苷4是其他可能用作抗COVID-19疾病治疗药物的先导分子。所研究的分子可作为一种有效的抗COVID-19抑制药物。